Anavex Life Sciences (AVXL) is a publicly traded Healthcare sector company. As of May 21, 2026, AVXL trades at $2.75 with a market cap of $266.89M and a P/E ratio of -4.95. AVXL moved +3.00% today. Year to date, AVXL is -30.38%; over the trailing twelve months it is -63.48%. Its 52-week range spans $2.61 to $14.44. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces AVXL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Anavex Life Sciences (AVXL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AVXL moved +3.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.75 |
| Market Cap | $266.89M |
| P/E Ratio | -4.95 |
| EPS | $-0.54 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.44 |
| 52-Week Low | $2.61 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $4.68M |
| Net Income | $-46.38M |
| Gross Margin | 0.00% |
2 analysts cover AVXL: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.00.